Confirmed Invited Speakers include the following.
Download invited speaker biographies here
Prof Stephen Keevil
Stephen Keevil has 30 years’ experience as a medical physicist in academia and the NHS. He is currently Head of Medical Physics at Guy’s and St Thomas’ NHS Foundation Trust. He is also Professor of Medical Physics and Director of the King’s Technology Evaluation Centre (KiTEC) at King’s College London. Professor Keevil has a long track record of involvement with the National Institute for Health Research (NIHR), including membership of the Research for Patient Benefit (RfPB) London Regional Advisory Committee (2010-2014) and of the Healthcare Scientist Fellowship Scheme Review Panel (2009-2010 and 2012-2015), and has managed various NIHR funding streams within his own Trust. He is currently a member of the NIHR Clinical Research Network (CRN) Imaging Strategy Group, chaired by Professor Stephen Smye. Professor Keevil is Immediate Past President of IPEM.
Dr Christopher Austin
A UK trained radiologist with qualifications in biomedical informatics and epidemiology, Dr. Christopher Austin has devoted his studies – and now his profession – to transforming healthcare with data and analytics.
Currently the Medical Director of Imaging AI and Analytics at GE Healthcare, Dr. Austin is responsible for leveraging the company’s deep expertise in diagnostic imaging equipment, software and data science, to design, validate and implement artificial intelligence capabilities into healthcare. Specifically, Dr. Austin is the clinical lead for GE’s unique deep learning partnerships. Working with world-class academic partners, including the University of California San Francisco Medical Center, Boston Children’s Hospital, Massachusetts General Hospital, Brigham and Women’s Hospital, and others, he architects deep learning applications that have the potential to enhance radiologist productivity, augment diagnostic confidence, and improve patient care globally.
Dr. Austin has been quoted in Fast Company, Aunt Minnie, DotMed and other healthcare news publications. He holds a medical degree from the University of Glasgow, an MSc in Epidemiology from the London School of Hygiene and Tropical Medicine, and trained in radiology at University College London Hospital. He resides in Seattle with his Scottish wife and three children.
Prof Gareth Barnes
Gareth Barnes graduated from York University U.K. as an electronic engineer in 1988. He spent his Ph.D. working on the country’s first multi-channel Magnetoencephalography (MEG) system at Aston University U.K. and the institute of Radio-engineering and Electronics in Moscow. After his Ph.D. and post-docs in Germany and Canada he returned to Aston to work on the U.K.’s first whole-head MEG system. In 2009 he moved to UCL where he heads the MEG development at the Wellcome Centre for Human Neuroimaging. Most of his research has focused on the development of methods to estimate brain activity based on these measurements. Most recently, in collaboration with Matthew Brookes and Richard Bowtell in Nottingham, he has been developing a new type of MEG system based on non-cryogenic sensors.
Dr Richard Black
Dr Black is Senior Lecturer in Bioengineering in the Department of Biomedical Engineering, and whose academic, teaching and research experience spans more than 25 years. He gained his PhD at the University of Liverpool where he was lecturer in Medical Device Design, and latterly a Principal Investigator at the UK Centre for Tissue Engineering. He is currently Academic Director of the UK Engineering and Physical Sciences Research Council (EPSRC) Centre for Doctoral Training in Medical Devices and Healthcare Technologies, which provides interdisciplinary research training at the interface between engineering, physical and life sciences for up to 40 students at any one time.
A Chartered Scientist and Engineer, he is a Fellow of the Institution of Mechanical Engineers and the Institute of Physics and Engineering in Medicine. He is currently Editor-in-Chief of Medical Engineering and Physics, one of three leading scientific journals published by the Institute.
Dr Helen Bodmer
Dr Helen Bodmer is head of the MRC, BBSRC and National Academies team in the Science, Research and Innovation Directorate of the Department for Business, Energy and Industrial Strategy. She is responsible for policy on basic and strategic medical research and broader life sciences research and for sponsorship of the MRC and BBSRC. She is also responsible for the relationship with the four National Academies which receive funding from the BEIS science budget – RAEng, Royal Society, British Academy and Academy of Medical Sciences. She is currently leading a review in the department looking at the local growth impacts of Public Sector Labs. She was previously UK Delegate for the European Research Council, part of the Excellent Science Pillar of H2020 and has been a policy fellow of the Centre for Science and Policy based in Cambridge. Helen is medically and scientifically qualified as a member of the Royal College of Physicians and with a DPhil from the Faculty of Clinical Medicine in Oxford. She has a background in immunology with 17 years of research experience in Mill Hill, Oxford, Strasbourg then coming back to Oxford as a Wellcome Trust senior clinical fellow before moving to Compton as a Group leader. She has a specific interest in T cell responses in infection and autoimmune disease. She practiced medicine doing regular clinics in rheumatology for many years before joining the civil service. Prior to her current post she spent four and a half years as an inspector in the Home Office Animals (Scientific Procedures) Inspectorate.
Dr Marco Brambilla
Dr. Marco Brambilla is head of the medical physics department at the University Hospital of Novara. He is teaching medical statistics at the specialization school for medical physics at the University of Turin. Prior to this appointment, he worked from 1991 to 2000 as Medical Physicist at the Hospital of Novara, Dept. of Nuclear Medicine with special topics on calibration, quality assurance and optimization of gamma cameras and PET scanners. He is Radiation Protection Expert of the University Hospital of Novara. Since 2012 he is Secretary General of the EFOMP and since 2017 Vice President of the EFOMP where he established from 2014 the EFOMP European School for Medical Physics Expert (ESMPE).
Paul Charnock is a RPA/MPE for IRS ltd based in Liverpool. Paul has worked for IRS since 2003 in the field of diagnostic radiology with a specialisms in patient dose audit methodologies, QA, dental and CT. Paul has co-authored a number of papers on using large data sets to establish regional dose reference levels
Paul is lead RPA for a couple of major Trusts and has begun to work with those Trusts in order to implement the findings of the COMARE 16 report by being part of a multi-disciplinary team looking at optimisation of CT scans
Prof David Clifton
Professor Clifton is with the Department of Engineering Science of the University of Oxford, and is a Governing Body fellow of Balliol College, Oxford. He is a Research Fellow of the Royal Academy of Engineering, and leads the Computational Health Informatics (CHI) Laboratory. A graduate of Oxford's Department of Engineering Science, Prof. Clifton trained in information engineering; his research focuses on the development of machine learning for tracking the health of complex systems, with an emphasis on healthcare technologies that are deployed within the UK National Health Service. Prof. Clifton's research has been awarded 21 scholarships and prizes, including a Grand Challenge award from the UK Engineering and Physical Sciences Research Council, which is a personal award that provides long-term strategic support for nine "future leaders in healthcare".
Dr David Compton
David graduated with a BEng (Hons) in Electrical and Electronic Engineering from Portsmouth University in 1993 and then completed a PhD at the University College London in Electrical Engineering. David joined the Forensic Science Services (FSS) in 1997 working in the Research and Development team on a European Forensic Imaging project before establishing a range of digital forensic capability which obtained UKAS accreditation to ISO 17025. After leaving the FSS, David started as an Assessment Manager at the United Kingdom Accreditation Service (UKAS) with responsibility for undertaking assessment of organisation involved in testing, inspection and certification activities. In 2015 David moved into the development section as a Project Manager and now has the responsibility for developing the UKAS accreditation scheme for Medical Physicals and Clinical Engineering (MPACE).
Prof John Damilakis
John Damilakis is full professor and chairman at the Department of Medical Physics, Faculty of Medicine, University of Crete, chairman of the Division of Radiology at the University of Crete and director of the Department of Medical Physics of the University Hospital of Heraklion, Crete, Greece. He is chairman of the International Organization for Medical Physics (IOMP) Education and Training committee and member of the Board of Directors of IMPCB (International Medical Physics Certification Board). Prof. Damilakis is coordinator or an active research member of several European and national projects. Most recent projects: EUCLID (European study on clinical DRLs for X-ray Medical Imaging), EC project, Scientific Coordinator, kick-off meeting September 2017 and MEDIRAD (Implications of MEDIcal Low Dose RAdiation Exposure), Horizon 2020, WP2 leader, kick-off meeting June 2017.
His publications have been focused on medical dosimetry and medical radiation protection. Number of publications in PubMed: 192, number of citations 3511, h-index 31. Many of these publications are in leading journals such as Medical Physics, Physics in Medicine and Biology, Radiology, Investigative Radiology and European Radiology. John Damilakis is editor of 1 book and co-author of 2 chapters in international textbooks. He is a member of the steering committee of the ‘Inter-University Postgraduate Course in “Medical - Radiation Physics’, Greece (1998-today). He has given more than 300 invited presentations in national and international conferences including ECR, RSNA, AAPM, IOMP and EFOMP meetings. John Damilakis is past president of the Hellenic Association of Medical Physicists, Senior Editor of BJR/Case Reports, Section Editor of the European Radiology and editorial board member of several scientific journals. He has received several awards in recognition of his work in the field of Medical Physics.
Dr Patrick A Finlay
Dr Patrick Finlay is an engineer and entrepreneur with a background in the research and development of medical robotics. He is Chief Executive of the Institute of Measurement and Control, the engineering institution concerned with sensors and automation.
After leading the government’s National Medical Robotics Programme in the 1980s, he was one of the key figures in the early growth of medical robotics, including developments in neurosurgery, orthopaedics and rehabilitation. He founded Armstrong Healthcare (now FreeHand Ltd), an international supplier of a specialist robot for laparoscopic surgery.
Patrick is a member of the Royal Academy of Engineering’s biomedical focus group and immediate past chairman of the Biomedical Engineering Association. He is a Trustee of the Institution of Mechanical Engineers and is keenly committed to supporting young engineers at the start of their careers.
He has an engineering degree from the University of Birmingham and a PhD in automation from Strathclyde University. He is honorary associate of the Institute of Neurosurgery and an expert adviser to the European Commission. He is a member of the Editorial Board of two journals and the author of over 20 patents and many technical papers.
Dr George Frodsham
George Frodsham founded MediSieve after being awarded his PhD in biochemical engineering from University College London (UCL), during which he developed the magnetic blood filter that MediSieve is commercialising - a platform medical device for the treatment of blood-borne diseases. As well as being a physicist and engineer, George is an entrepreneur.
George was awarded a BBSRC Enterprise Fellowship from the Royal Society of Edinburgh in 2014. Since 1996, only 180 individuals have benefited from this highly competitive programme. He is also a member of the Royal Academy of Engineering Enterprise Hub, having completed the Enterprise Fellowship programme after being runner up in the ERA Foundation Entrepreneurs Award. He has also completed the Entrepreneurship Summer School programme at the London Business School. This training equipped him to research target markets and industries and turn his visions into viable businesses.
George has now been running MediSieve for 2.5 years, securing over £1M in equity funding and over £250k of grants while bringing the technology through pre-clinical trials. During that time, MediSieve has been one of the winners of Pitch@Palace 5.0 and a finalist in the accelerator MassChallenge, and had extensive coverage both online and in national newspapers.
Claire started her professional career at Velindre Hospital in Cardiff, where she followed the Medical Physics Basic Grade Training scheme. She then spent eight years working in France as a medical physicist in a combination of research, teaching and clinical roles and became the first non-French trained medical physicist to attain national registration. Since returning to the UK Claire has worked at Mount Vernon Cancer Centre, where she is now a Consultant Clinical Scientist and Radiation Protection Adviser (RPA).
As Training Coordinator for the North London Medical Physics consortium and Lead Healthcare Scientist for East & North Herts NHS Trust, Claire has been involved with the development and implementation of the Modernising Scientific Careers (MSC) training programmes since their inception.
She has held the position of Professional Lead for Medical Physics and Clinical Pharmaceutical Sciences at the National School of Healthcare Science (NSHCS) since 2014.
Claire is a fellow of the Institute of Physics & Engineering in Medicine (IPEM) and has held various roles within the Institute, most recently as Director of the Professional & Standards Council (2013-15) and has also chaired the European Federation of Organisations for Medical Physics (EFOMP) Professional Matters Committee (2011-13).
Dr Peter Jarritt
Formally the Clinical Director of Medical Physics and Clinical Engineering, Addenbrooke’s Hospital, Cambridge. He retains a part-time position as a Consultant Healthcare Scientist at Cambridge University Hospitals. He worked with the British Standards Institute as chair of BS70000 working party developing a British Standard for the quality improvement of Medical Physics and Clinical Engineering products and services. He is also chair of the UKAS Technical Advisory Committee advising on the implementation of an accreditation scheme for Medical Physics and Clinical Engineering services. He is the Deputy Director of the National Institute for Health Research Health Technology Co-operative (HTC) for Brain Injury leading their Medical Devices theme. The HTC is established to support the translation of innovation, research and development into commercially available products and to support small and medium sized enterprises through the regulatory and quality processes.
He is a Past President and Fellow of the Institute of Physics and Engineering in Medicine and an Honorary Fellow of the Royal College of Physicians.
Prof Josef Käs
Professor Josef Käs’s career started in the well-known biological physics group of Prof. Erich Sackmann in Munich. During his postdoctoral stay in Professor Paul Janmey’s group at Harvard Medical School he developed the first theory for the elastic behavior of the cellular cytoskeleton.
As a professor at the University of Texas at Austin he invented the optical stretcher; a new optical trapping technology to measure the viscoelastic properties of whole single cells. He then went onto the University of Leipzig where he successfully expanded his research in neurosciences and oncology.
Throughout his career he has performed innovative research in cell biophysics. His research has helped in the understanding of the role of cell biomechanics in tumor progression; an important part of the emerging physics of cancer.
Dr Mika Kortesniemi
Mika Kortesniemi is adjunct professor at the University of Helsinki and chief physicist at the HUS Medical Imaging Center, Radiology, Helsinki University Hospital, Finland. He is the chairman of the Science Committee of the European Federation of Organisations for Medical Physics (EFOMP), associate editor in Physica Medica journal and member of the International Organization for Medical Physics (IOMP) Education and Training committee.
His professional focus is on the quality assurance, dosimetry, optimisation and radiation protection in x-ray modalities, especially the evolving multi-slice CT technology. The research work is primarily related on radiological optimisation, currently emphasizing the use of anthropomorphic phantoms and Monte Carlo simulations. Number of publications in Scopus: 57, number of citations 764, h-index 15. Dr Kortesniemi is also involved in several national and international projects, including European H2020 research, IAEA activities and quality audits in the field of medical imaging.
Efi Koutsouveli received her MSc degree in Medical Physics from the University of Surrey, UK following a BS degree in Physics at the National & Kapodistrian University of Athens, Greece. She is a Medical Physicist in the Medical Physics department of Hygeia Hospital, Athens since 1993. Her professional focus is on quality assurance, dosimetry, radiation protection of radiotherapy units (external radiotherapy & brachytherapy), pediatric, stereotactic radiotherapy, radiosurgery treatments and patient safety. She is also active in the training of young Medical Physicists, Radiation Oncologists, Radiation Therapists, Nurses, Administrative staff in the field of radiation protection and Oncology Information Systems. Her special interest is on Hospital Quality Management Systems, Risk Management, Radiotherapy Quality Audits and she is serving on multiple hospital quality committees since 1996.
She is the Public Affairs and Communications responsible for the Hellenic Association of Medical Physicists (HAMP), the HAMP-ESTRO liaison person and the HAMP delegate to EFOMP and IOMP since 2014. She is currently the European Federation of Organisations for Medical Physics (EFOMP) Internet Manager and Secretary of the EFOMP Communications & Publications Committee as well as member of the European School of Medical Physics Expert (ESMPE) board and one of the editors of the EFOMP European Medical Physics News. She is also member of the International Organisation for Medical Physics (IOMP) web and women subcommittees.
Prof Andrew Lewis
Andy has experience of developing products within small, medium and large companies, having spent his early career with ICI working in the area of advanced polymermembranes and subsequently with Johnson & Johnson leading projects in absorbent technologies. Andy joined Biocompatibles in 1996 and is Director of R&D in Innovation (now part of BTG). He specialises in the development of advanced biomedical polymer systems, for instance, to enhance the biocompatibility of implants or to modulate delivery of active agents in the body. These technologies have been applied to novel drug-device combination products for use in interventional therapies in the treatment of cardiovascular disease and cancer and have resulted in around a dozen products reaching commercialisation.
Andy has generated around 220 scientific peer-reviewed publications and articles (H-index 52), 11 book chapters and 50 patent families/applications in the fields of polymers, biomaterials and drug delivery. He is Professor of Biomaterials & Drug Delivery at the University of Brighton where he lectures on Drug-Device Combination Products and in 2015 was recognised by the scientific community with the award of the Chapman Medal for distinguished research in the field of biomedical materials, particularly with respect to biomaterials innovation, which has produced benefits for patients and/or contributed to associated opportunities for industry.
Dr Helen Meese
Dr Helen Meese is Head of Healthcare at the Institution of Mechanical Engineers. She works on behalf of the Institution’s 115,000 members, managing its programmes on all aspects of health and social care, focusing on medical equipment, pharmaceutical production, innovative healthcare technologies and their impact on both UK and global communities. Through peer reports, public speaking and policy development she engages with clinicians, government and the media to raise the profile of biomedical and mechanical engineering and its contribution to the health and wellbeing sectors.
She is an Electro-Mechanical Power Engineer with over 20 years of experience in both academia and industry. Her academic career was spent at Loughborough University researching turbocharger performance characteristics and developing electrical defence systems for armoured vehicles. Her industrial career was predominantly in the defence industry working for Babcock International and GE Energy, where she managed projects on euro-fighter typhoon, submarine systems and naval vessels.
Prof Stephen O'Connor
Stephen O’Connor attended King’s College and Medical College of St. Bartholomew’s Hospital, University of London for his undergraduate and postgraduate studies.
His early research was in respiratory physiology with chest physicians and anaesthetists. He left the NHS and pursued a career in industry in exciting areas of breakthrough medical device technologies designed to improve diagnosis, treatment and, most importantly, patient outcomes. He was responsible for pivotal clinical trials in neuro stimulation for epilepsy, depression and Alzheimer’s disease, as well as in the cardiac field on cryo-ablation, biventricular pacing for heart failure, transvenous and subcutaneous implantable cardioverter defibrillators.
Stephen is a Fellow of IPEM and IOP and an honorary Fellow of the Royal College of Physicians. He is currently Chair of the Fellowship Panel of IPEM and a member of the Professional Conduct Committee. Stephen is a Visiting Professor at City, University of London and sits on the Strategic Advisory Board for Mathematic, Computer Science and Engineering.
Prof Heidi Probst
Prof Probst qualified as a Therapeutic Radiographer in 1987 and worked for the NHS (primarily for the Leeds Teaching Hospitals NHS Trust) for 14 years prior to joining Sheffield Hallam University as a senior lecturer. Prof Probst was appointed Reader in Radiotherapy in 2013 and Professor of Radiotherapy and Oncology in June 2015
Prof Probst research interests are in radiotherapy for breast cancer, research capacity development in Radiography, workforce development and e-learning. Prof Probst is founder and chair of a Breast Radiotherapy Interest Group (BRIG) with over 100 members from the UK and overseas.
Dr David Roberts
David Roberts, PhD is a Physics team leader within the Engineering research and development department at Elekta. Elekta is a global medical technology company developing solutions for cancer and brain disorders employing over 3,500 people globally.
David has an academic and industrial background previously working in the NHS as a medical physics trainee; a PhD in Medical Physics from The Institute of Cancer Research and finally within R and D at Elekta. His interests are the design of new radiotherapy devices with a particular focus on computer modelling (Monte Carlo).
At Elekta he has been involved in the design and testing of Agility™, Elekta’s latest generation beam shaping device and the flattening filter free delivery system. For the past 5 years he has been leading the physics activities on Elekta’s MR-Linac with respect to the delivery and imaging device design. This system combines a 1.5T MR imaging system, a 7MV linear accelerator and an adaptive treatment workflow.
Prof Ralph Sinkus
Being a physicist with a background in high energy physics, nuclear physics and MRI, I was working with my research team in Paris in a scientific and yet clinical environment strongly oriented towards translational research (University Paris Diderot, Sorbonne Paris Cité, Hôpital Beaujon, Paris, France).
I spent half of my scientific career in industry and half in academia. During my PhD in high energy physics (DESY, Deutsches Elektronen Synchrotron, Hamburg, Germany) I worked on quantum electrodynamics and chromodynamics and developed a neural-network based system to identify electrons in inelastic elementary particle collisions. After my PhD (1997) I took a position at Philips Medical Systems Research Laboratories in Hamburg, Germany. My main focus of research was in the domain of MRI and in particular in the field of MR-elastography (MRE).
In 2004 I decided to leave the industrial research in order to further develop my academic career. I followed a call to the “Laboratoire Ondes et Acoustique”, ESPCI, Paris, France and was offered a 3 years position as research director (CNRS) in order to establish a MRI group. My academic research activities were accompanied by collaboration with a newly founded ultrasound company (Supersonic Imaging, France). In 2007 I obtained a permanent position as research director at CNRS. This inspired me to move towards a new scientific environment offering me the possibilities to have access to three spatial scales: molecular and cellular level, small animal scale, and access to patients. Hence, I was able to develop more freely and comprehensively my own research program. My team in Paris had 9 members (2 permanent researchers, 5 post-docs and 2 PhD’s). I have close collaborations with many international research institutes: Neura Research Center Sydney, Australia; Prince of Wales Hospital, Hong Kong; University Hospital Lübeck, Germany; University of British Columbia, Vancouver, Canada; NIH, Bethesda, Maryland, USA; University of Minnesota, Minneapolis, USA; University of Oslo, Norway; The Institute of Cancer Research and Royal Marsden NHS Trust, Sutton, UK; Yonsei University College of Medicine, Seoul, and Samsung Hospital, Seoul, Korea.
My current research activities are mainly focused on the assessment and the understanding of biomechanics within the human body for disease characterization and therapy efficacy evaluation by using MR and ultrasound elastography. This interest goes far beyond the “plain” measurement of tissues’ viscoelastic properties, but reaches out into fundamental physics such as for instance anomalous wave propagation in fractal-like media and apoptotic cellular processes triggered via mechanotransduction.
At present, I envisage 4 main stream research foci in order to complement and extend the current research portfolio in the bioengineering group at KCL:
Nishan Sunthares is Chief Operating Officer of ABHI. He is responsible for leadership of the Association, and is an Executive Director of the ABHI Board.
Nishan joined ABHI in 2010 and has overall ownership of the Association’s work programmes across its strategic pillars. Nishan’s regular, personal interaction with government Ministers, senior NHS officials and hospital Chief Executives has been key to increasing the Association’s impact. He leads the industry’s response to the increasingly challenging commercial environment. Nishan is currently involved in in engaging with NHS Improvement and local NHS leadership to ensure new models of care maximise the value and contribution from medical technologies.
After completing his degree in Medical Sciences, Nishan trained as a management accountant specialising in IT and software accounting. Nishan has worked in the medical technology industry for 15 years, and has held roles in finance, market access, as well as sales and marketing management. He serves on the Digitalhealth.London Advisory Panel and the NHS Supplier Board.
Prof Azzam Taktak
Azzam Taktak is a Consultant Clinical Scientist at the Royal Liverpool University Hospital and an Honorary Professor at the University of Liverpool. He previously held the office of Vice President of Engineering at the IPEM. He is a national assessor at the Association of Clinical Scientists and lead assessor at the National School for Healthcare Scientists. His main research interests are mathematical and statistical modelling and the use of artificial intelligence and machine learning in medicine. To date he has published more than 75 peer-reviewed articles and edited 2 books.
Dr Virginia Tsapaki
Currently, head of the medical physics department at Konstantopoulio General Hospital of Athens, Greece. 25 years of experience in Diagnostic and Interventional Radiology and Nuclear Medicine. International Atomic Energy Agency (IAEA) expert sent in more than 20 missions for the last 13 years. Participated in multiple European projects (BSS Transposition Project, ENETRAP III, Paediatric DRLs, EUTEMPE-RX, EMAN, SENTINEL, DOSEDATAMED II, DIMOND II and III). International Organization for Medical Physics (IOMP) Secretary General for the term 2015-2018, e Medical Physics World Newsletter and IOMP website chair for 2012-2015. Founder and Chair of the IOMP Women Subcommitte 2015. EFOMP Chair of Communications and Publications Committee during the term 2012-2013 and the EFOMP Projects Committee for the term 2016-2017. Secretary General of the Hellenic Association of Medical Physicists (HAMP) for the term 2010-2012 and HAMP President for the terms 2012-2014, 2014-2016 and 2016-2018. Member of Organizing, Scientific Committee, International Advisory Committee or chair of various international conferences in the last 4 years. Editorial member of the European Journal of Medical physics (EJMP) and Medical Physics International. Section editor of the Hellenic Radiology Journal. Quest editor of 2 special issues of EJMP. Honorary Editor of IOMP eMPW. More than 110 publications in SCI journals and national and international journals or conference proceedings. More than 170 presentations and posters in national and international conferences. IOMP Fellow in 2016. Field of expertize: Patient and staff dosimetry, optimization, diagnostic reference levels, dose tracking software.
Graeme is Group Manager for Devices Regulatory Affairs at the Medicines and Healthcare products Regulatory Agency (MHRA). He is responsible for teams dealing with notified body oversight, clinical investigation approval, compliance investigations, borderline and classification issues and implementation of new EU medical device legislation.
Graeme has been a civil servant for 13 years and has spent his career working primarily on healthcare policy. He has previously held Deputy Director roles at the Department of Health and also spent 18 months as Private Secretary to the Secretary of State for Health.
Prof Marco Viceconti
Marco Viceconti holds the chair of Biomechanics at the Department of Mechanical Engineering of the University of Sheffield, UK, and serves as Executive Director of the Insigneo Institute for in silico Medicine (www.insigneo.org), a joint initiative of the University of Sheffield and the Sheffield Teaching Hospital NHS Foundation Trust. He is also professor associate in the department of Oncology and Metabolism. Prof Viceconti is an expert of musculoskeletal biomechanics in general, and in particular in the use of subject-specific modelling to support the medical decision. He is one of the key figures in the Virtual Physiological Human (VPH) community: he is the President of the VPH Institute, an international no-profit organisation that coordinates this research community, and has recently concluded the coordination of the Avicenna action, which road-mapped the emerging topic of “in silico clinical trials”, where subject-specific modelling is used in the development and assessment of biomedical products. Prof Viceconti has 316 publications indexed in Scopus (H-index = 40). Since his relocation in UK in 2011, he became Fellow of IMEchE and of IPEM.
Stefan Wijnen has worked in various roles for Microsoft since 2006. In the Belgian subsidiary, he was a Technology Strategist and Business Manager for government and healthcare customers. In 2014, Stefan moved to Microsoft Corporate in the US to assume the role of Industry Solution Manager being responsible for the Cloud Platform within the Worldwide Healthcare team. Recently he has joint Microsoft Research in the United Kingdom (Cambridge) as Business Development and Partner Manager to work in the InnerEye team, an artificial intelligence technology to do medical image analysis to assist radiation oncologists in the treatment of tumors. It allows them to achieve 3D contouring of patients’ planning scans in minutes rather than hours. The assistive AI technology gives the experts full control of the output accuracy, while enjoying high levels of consistency, and enormous cost savings.
Prior to joining Microsoft, he has spent the majority of his career in IT security for Philips, Utimaco and Certipost, managing initiatives as the Public Key Infrastructure (PKI) for the Belgian national eID card.
Prof Steve Williams
Professor Steve Williams is the founder and Head of Department of Neuroimaging at the Centre for Neuroimaging Sciences, based at the IoPPN and Maudsley Hospital, King’s College London. Steve has co-authored over 700 papers and chapters in leading neuroscience journals and has already achieved an h-index of >130 and more than 70,000 citations for his work. He has also recently made it into google’s top 500 most highly cited researchers of all time (http://www.webometrics.info/en/node/58).
He graduated from Loughborough University in 1985 and spent a formative year working for Beecham Pharmaceuticals in Harlow before seeking the first ever PhD in Magnetic Resonance Imaging from the University of Cambridge. He went on to set up a University of London Intercollegiate Imaging facility which focused on the development and application of magnetic resonance techniques in a wide range of pre-clinical models of disease. In the mid ’90s he then moved to the Institute of Psychiatry to champion the application of neuroimaging in a broad range of neurological and psychiatric disorders and, in 2014 he was elected a Fellow to the Academy of Medical Sciences in recognition of his scientific achievements.
For the past decade Steve has aimed to make brain imaging an essential clinical tool in neuropsychiatry and continues to develop innovative imaging methods to measure structure, function, physiology and metabolism.
He is extremely grateful for the wide range of funding which supports him and his department. These include the Wellcome Trust, NIHR, Medical Research Council, EPSRC and European Union as well as numerous industrial partners including GSK, GE Healthcare, Pfizer, Lilly, Roche, Eisai, Takeda, Janssen and Bionomics.
© Institute of Physics and Engineering in Medicine
Registered in England and Wales (No. 3080332)
Registered Charity (No.1047999)